Evidence map›Paper›PMID 21950524›Full record

ArticleBritish journal of pharmacology2012

Ursolic acid induces apoptosis in human leukaemia cells and exhibits anti-leukaemic activity in nude mice through the PKB pathway.

Ning Gao, Senping Cheng, Amit Budhraja, Ziyi Gao, Jieping Chen, E-Hu Liu, Cheng Huang, Deying Chen, Zailin Yang, Qun Liu and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Cytotoxic Effects of Pinnatane A Extracted fromMolecules (Basel, Switzerland) · 2018
    Article
  12. Ursolic acid facilitates apoptosis in rheumatoid arthritis synovial fibroblasts by inducing SP1-mediated Noxa expression and proteasomal degradation of Mcl-1.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  13. Article
  14. [Effect of ursolic acid on proliferation and apoptosis of human osteosarcoma cell line U2-OS].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2017
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Ning GaoDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
Senping ChengDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
Amit BudhrajaDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
Ziyi GaoDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
Jieping ChenDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
E-Hu LiuDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
Cheng HuangDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
Deying ChenDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
Zailin YangDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
Qun LiuDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
Ping LiDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
Xianglin ShiDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
Zhuo ZhangDepartment of Pharmacognosy, College of Pharmacy, 3rd Military Medical University, Chongqing, ChinaGraduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KentuckyDepartment of Hematology, Southwest Hospital, 3rd Military Medical University, Chongqing, ChinaKey Laboratory of Modern Chinese Medicines (China Pharmaceutical University), Ministry of Education, Nanjing, China.
University of Kentucky · USArmy Medical University · CNChina Pharmaceutical University · CNSouthwest Hospital · CN

Funding

Apple Peel Extract Protects UV-Induced CarcinogenesisR01ES015375 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN · 2006 to 2010
$1.7M
Quercitrin functions as an antioxidant and protects UV-induced carcinogenesisR21ES019249 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN, ZHANG, ZHUO · 2011 to 2012
$408k
NIEHS NIH HHS 1R21 ES019249NIEHS NIH HHS R01 ES015375NIEHS NIH HHS R21 ES019249
6 · The paper itself

Abstract

background and purposeUrsolic acid (UA) has been extensively used as an anti-leukaemic agent in traditional Chinese medicine. In the present study, we investigated the ability of UA to induce apoptosis in human leukaemia cells in relation to its effects on caspase activation, Mcl-1 down-regulation and perturbations in stress-induced signalling pathways such as PKB and JNK. EXPERIMENTAL APPROACH: Leukaemia cells were treated with UA after which apoptosis, caspase activation, PKB and JNK signalling pathways were evaluated. The anti-tumour activity of UA was evaluated using xenograft mouse model. KEY

resultsUA induced apoptosis in human leukaemia cells in a dose- and time-dependent manner; this was associated with caspase activation, down-regulation of Mcl-1 and inactivation of PKB accompanied by activation of JNK. Enforced activation of PKB by a constitutively active PKB construct prevented UA-mediated JNK activation, Mcl-1 down-regulation, caspase activation and apoptosis. Conversely, UA lethality was potentiated by the PI3-kinase inhibitor LY294002. Interruption of the JNK pathway by pharmacological or genetic (e.g. siRNA) attenuated UA-induced apoptosis. Furthermore, UA-mediated inhibition of tumour growth in vivo was associated with induction of apoptosis, inactivation of PKB as well as activation of JNK. CONCLUSIONS AND IMPLICATIONS: Collectively, these findings suggest a hierarchical model of UA-induced apoptosis in human leukaemia cells in which UA induces PKB inactivation, leading to JNK activation and culminating in Mcl-1 down-regulation, caspase activation and apoptosis. These findings indicate that interruption of PKB/JNK pathways may represent a novel therapeutic strategy in haematological malignancies.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisCaspasesCell Line, TumorLeukemiaMAP Kinase Kinase 4MiceMice, Inbred NODMice, SCIDMyeloid Cell Leukemia Sequence 1 ProteinPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2TriterpenesAntineoplastic Agents, PhytogenicCaspasesMAP Kinase Kinase 4Mcl1 protein, mouseMyeloid Cell Leukemia Sequence 1 ProteinParp1 protein, mousePoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2TriterpenesUrsolic Acid

Identifiers

PMID21950524
PMCPMC3372832
OpenAlexW1927915280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.